Ep16 - FDA's QMM Program

Update: 2022-11-15

Description

In this episode, NoviSystems CEO, Mike Kowolenko, and Chief Quality Advisor, Juan Torres, explore the FDA's Quality Management Maturity program, what it means for biopharma manufacturing operations, and its objective to reduce drug shortages.

Comments

In Channel

Ep19 - Science-backed FDA Investigations

2022-12-0620:45

Ep18 - Validation in Today's Data-Driven Environment - Part 2

2022-11-2922:57

Ep17 - Validation in Today's Data-Driven Environment

2022-11-2224:50

Ep16 - FDA's QMM Program

2022-11-1523:36

Ep15 - Origins of NoviSystems

2022-11-0811:02

Ep14 - Working with Data Scientists

2022-11-0214:32

Ep13 - Digital Transformation for Drug Product Release

2022-10-2520:09

Ep12 - Change is a Requirement for Quality

2022-10-1821:41

Ep11 - Managing Fear of Change in Quality Organizations

2022-10-1121:02

Ep10 - Management Review is Good Business

2022-10-0425:49

Ep9 - Product Release with AI and Machine Learning

2022-09-2719:51

Ep8 - The Product is the Process

2022-09-2118:35

Ep7 - Quality, Innovation, and Culture

2022-09-1321:50

Ep6 - Machine Learning

2022-09-0618:59

Ep5 - Management Review

2022-03-3015:18

Ep4 - Corrective and Preventive Actions

2022-03-3016:17

Ep3 - Data Driven Decision Making for Drug Product Release

2022-03-0319:55

Ep2 - Proving Compliance and State of Control

2022-02-1317:48

Ep1 - Quality vs Manufacturing

2022-02-1317:10

00:00

#box-pro-ellipsis-176439050995587{-webkit-line-clamp:2;}Ep16 - FDA's QMM Program

Ep16 - FDA's QMM Program

NoviSystems

Ep16 - FDA's QMM Program